Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

Fast fashion's quick work

Sep 23, 2019

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

This cancer patient is devoting his life to making drugs more affordable

by Dan Gorenstein May 17, 2017
David Mitchell's advocacy group aims to bring down prescription prices by harnessing the power of patient stories.
Advocate David Mitchell says drugs are so expensive that some people are losing their homes or using college savings. Above, chemotherapy drugs.
Chris Hondros/Getty Images

Why health care is like a Rubik's Cube

by Kai Ryssdal and Robert Garrova Apr 12, 2017
Dr. Elisabeth Rosenthal talks about her new book and the danger of all-or-nothing politics.
PATRIK STOLLARZ/AFP/Getty Images

Trump tells big pharma to cut their 'astronomical' drug prices

by David Brancaccio Feb 1, 2017
Will drug companies agree to the president's proposal?
 President Donald Trump meets with representatives from PhRMA, the Pharmaceutical Research and Manufacturers of America, on Tuesday.
Ron Sachs - Pool/Getty Images

Clinton drug plan: is it enough?

by Dan Gorenstein Sep 2, 2016
What would it take to control drug prices?
Rather than tackling the soaring prices of drugs overall, Clinton economic policy advisor Mike Shapiro said their plan is to address the insidious problem where a subset of drug makers crank up prices on generics, just because they can.
FRANCK FIFE/AFP/Getty Images

Drug prices still escalating and not stopping any time soon

by Dan Gorenstein Jul 14, 2016
Drug price inflation soars even as prices in the wider economy are stable.
Americans continue to spend on drugs at an increasing rate. 
Tim Boyle/Getty Images

New class of generics could save consumers, insurers billions. FDA is moving carefully.

by Dan Gorenstein Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images

Turns out hedge funds have an incentive to control drug prices

by Dan Gorenstein Apr 25, 2016
Hedge funds are joining groups who want to lower prescription prices for consumers.
Big Pharma doesn't like the patent review board. But organizations that want to lower prescription prices for consumers love it, and they're being joined in their fight by people who aren't usually seen as champions of consumer rights — hedge fund managers.
Photo by Joe Raedle/Getty Images

Invest in Marketplace today

Ask not what Marketplace can do for you, but what you can do for Marketplace.

Valeant's story: a cautionary tale

by Dan Gorenstein Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 
BRENDAN SMIALOWSKI/AFP/Getty Images

Bad packaging means $3b in drugs will be wasted this year

by Dan Gorenstein Mar 1, 2016
A new report suggests drug makers are profiting from the waste.
A new report suggests drug makers are profiting from the waste.
Peter Macdiarmid/Getty Images

How CVS reined in drug prices

by , and Feb 23, 2016
Its Caremark unit covers some 25 million U.S. customers
Spencer Platt/Getty Images